Filed pursuant to Rule 433
Registration Statement Nos. 333-290665 and 333-290665-01
BofA Finance LLC
Fully and Unconditionally Guaranteed by Bank of America Corporation
Market Linked Securities
Market Linked Securities—Auto-Callable with Contingent Coupon and... (continue reading...)
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.Subject to completion dated June 23, 2026
June , 2026
... (continue reading...)Citigroup Global Markets Holdings Inc.
June 18, 2026
Medium-Term Senior Notes, Series N
Pricing Supplement No. 2026-USNCH32483
Filed Pursuant to Rule 424(b)(2)
Registration Statement Nos. 333-293732 and 333-293732-02
28,178 Contingent Income Auto-Callable Securities Due June 23, 2028
Based on the Worst Performing of the Nasdaq-100 Index® , the Russell 2000® Index and the S&P 500® Index
Principal at Risk... (continue reading...)
Filed pursuant to Rule 433
Registration Statement Nos. 333-290665 and 333-290665-01
BofA Finance LLC
Fully and Unconditionally Guaranteed by Bank of America Corporation
Market Linked Securities
Market Linked Securities—Auto-Callable with Contingent Coupon and... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: CLARK IAN T
-
Form 424B2 BofA Finance LLC
-
Form 424B3 CNL Strategic Capital,
-
Form D Kalea Ventures Funds
-
Form 424B2 HSBC USA INC /MD/
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Larson Yi
-
Form 6-K/A VivoPower PLC For: Jun 23
-
Form 11-K Liberty Energy Inc. For: Dec 31
-
Form D/A CAZ Private Equity Owner
-
Form 11-K Ingersoll Rand Inc. For: Dec 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Ballal Rahul D.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 425 Axalta Coating Systems Filed by: AKZO NOBEL NV
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Horning Sandra
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: CAPELLO JEFFREY D
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 4 Indivior Pharmaceuticals For: Jun 22 Filed by: Ciaffoni Joseph
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Foster-Cheek Kaye I
-
Form APP ORDR J.P. Morgan Investment
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K CNL Strategic Capital, For: Jun 23
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: Raman Prakash
-
Form 424B2 BofA Finance LLC
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form APP NTC J.P. Morgan Investment
-
Form DEF 14A 22nd Century Group, Inc. For: Jun 23
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: FOUSE JACQUALYN A
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Solidion Technology Inc.
-
Form 4 Olema Pharmaceuticals, For: Jun 18 Filed by: RAPPAPORT ANDREW
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form 4 Disc Medicine, Inc. For: Jun 18 Filed by: Khara Rahul
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form 424B2 BofA Finance LLC
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form 4 AGIOS PHARMACEUTICALS, For: Jun 18 Filed by: Ho Maykin
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30
-
Form NPORT-P NATIONWIDE MUTUAL FUNDS For: Apr 30

